Elsevier

Neuroscience

Volume 50, Issue 4, October 1992, Pages 831-846
Neuroscience

Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat

https://doi.org/10.1016/0306-4522(92)90207-IGet rights and content

Abstract

The influence of sustained epileptic seizures evoked by intraperitoneal injection of kainic acid on the gene expression of the neuropeptides somatostatin and neuropeptide Y and on the damage of neurons containing these peptides was studied in the rat brain. Injection of kainic acid induced an extensive loss of somatostatin and, though less pronounced, of neuropeptide Y neurons in the inner part of the hilus of the dentate gyrus. Neuropeptide Y-immunoreactive neurons located in the subgranular layer of the hilus, presumably pyramidal-shaped basket cells, were spared by the treatment. Although neuropeptide Y messenger RNA was not detected in granule cells of control rats, it was found there after kainic acid seizures at all time intervals investigated (12 h to 90 days after injection of kainic acid). High concentrations of neuropeptide Y messenger RNA were especially observed 24 h after injection of kainic acid. At this time neuropeptide Y messenger RNA was also transiently observed in CA1 pyramidal cells. Neuropeptide Y synthesis in granule cells in turn gave rise to an intense immunoreactivity of the peptide in the terminal field of mossy fibers which persisted for the entire time period (90 days) investigated. In addition, neuropeptide Y messenger RNA concentrations were also drastically elevated in presumptive basket cells located at the inner surface of the granule cell layer, especially at the “late” time intervals investigated (30–90 days after kainic acid).

These data support the concept that extensive activation of granule cells by limbic seizures contributes to the observed neuronal cell death in CA3 pyramidal neurons and interneurons of the hilus. Consecutively, basket cells containing neuropeptide Y and presumably GABA might be activated and participate in recurrent inhibition of granule cells. Neuropeptide Y-immunoreactive fibers observed in the inner molecular layer at “late” time intervals after kainic acid may result either from collateral sprouting of mossy fibers or from basket cells extensively expressing the peptide.

It is speculated that neuropeptide Y synthesized and released at a high rate from granule cells and basket cells may exert a protective action against seizures.

References (86)

  • FeldmanS.C. et al.

    Somatostatin neurons in the rodent hippocampus: an in vitro and in vivo immunocytochemical study

    Neurosci. Lett.

    (1982)
  • FreundT.F. et al.

    Pattern of neuronal death in the hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemie vulnerability

    Brain Res. Bull.

    (1992)
  • HiguchiH. et al.

    Rat neuropeptide Y precursor gene expression

    J. biol. Chem.

    (1988)
  • HökfeltT.

    Neuropeptides in perspective: the last ten years

    Neuron

    (1991)
  • KatoN. et al.

    Changes of immunoreactive somatostatin and β-endorphin content in rat brain after amygdaloid kindling

    Life Sci.

    (1983)
  • KöhlerC. et al.

    Somatostatin-like immunoreactive neurons in the hippocampus: an immunocyto-chemical study in the rat

    Neurosci. Lett.

    (1982)
  • KöhlerC. et al.

    Co-localization of neuropeptide tyrosine and somatostatin immunoreactivity in neurons of individual subfields of the rat hippocampal region

    Neurosci. Lett.

    (1987)
  • LothmanE.W. et al.

    Kainic acid incuced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates

    Brain Res.

    (1981)
  • MarksteinerJ. et al.

    Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy in the rat

    Neurosci. Lett.

    (1990)
  • MarksteinerJ. et al.

    Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels

    Eur. J. Pharmac.

    (1990)
  • MarksteinerJ. et al.

    Concomitant increase of somatostatin, neuropeptide Y and glutamate decar☐ylase in the frontal cortex of rats with decreased seizure threshold

    Neuroscience

    (1988)
  • MarksteinerJ. et al.

    Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat

    Neuroscience

    (1992)
  • McIntyreD.C. et al.

    Kindling mechanisms: current progress on an experimental epilepsy model

    Prog. Neurobiol.

    (1986)
  • MeldrumB. et al.

    Excitatory amino acid neurotoxicity and neurodegenerative disease

    Trends pharmac. Sci.

    (1990)
  • O'DonohueT.L. et al.

    Neuropeptide Y and peptide YY neuronal and endocrine systems

    Peptides

    (1985)
  • OkazakiM.M. et al.

    Protective effects of mossy fiber lesions against kainic acid-induced seizures and neuronal degeneration

    Neuroscience

    (1988)
  • OlpeH.-R. et al.

    Central actions of somatostatin

    Eur. J. Pharmac.

    (1980)
  • PisaM. et al.

    Spontaneous recurrent seizures after intracerebral injection of kainic acid in rats: a possible model of human temporal lobe epilepsy

    Brain Res.

    (1980)
  • PitkänenA. et al.

    Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain in pentylenetetrazol-induced kindling

    Peptides

    (1988)
  • PittmanQ.J. et al.

    Somatostatin hyperpolarizes hippocampal pyramidal cells in vitro

    Brain Res.

    (1981)
  • RepresaA. et al.

    Hippocampal plasticity in the kindling model of epilepsy in rats

    Neurosci. Lett.

    (1989)
  • RepresaA. et al.

    Hippocampal plasticity in childhood epilepsy

    Neurosci. Lett.

    (1989)
  • ScharfmanH.E. et al.

    Responses of cells of the rat fascia dentata to prolonged stimulation of the perforant path: sensitivity of hilar cells and changes in granule cell excitability

    Neuroscience

    (1990)
  • SchmechelD.E. et al.

    GABAergic neurons of mammalian cerebral cortex: widespread subclass defined by somatostatin content

    Neurosci. Lett.

    (1984)
  • SchwobJ.E. et al.

    Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study

    Neuroscience

    (1980)
  • SloviterR.S.

    “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies

    Brain Res.

    (1983)
  • SperkG. et al.

    Kainic acid induced seizures; neurochemical and histopathological changes

    Neuroscience

    (1983)
  • TavianiniM.A. et al.

    Isolation, characterization, and DNA sequence of the rat somatostatin gene

    J. biol. Chem.

    (1984)
  • VezzaniA. et al.

    A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201–995) modulates seizures induced by quinolinic and kainic acids differentially in the rat hippocampus

    Neuropharmacology

    (1991)
  • AmaralD.G.

    A Golgi study of cell types in the hilar region of the hippocampus in the rat

    J. comp. Neurol.

    (1978)
  • BabbT.L. et al.

    Glutamate decar☐ylase-immunoreactive neurons are preserved in human epileptic hippocampus

    J. Neurosci.

    (1989)
  • BakstI. et al.

    An experimental analysis of the origins of somatostatin-like immunoreactivity in the dentate gyrus of the rat

    J. Neurosci.

    (1986)
  • BealM.F. et al.

    Neuropeptides in neurological disease

    Ann. Neurol.

    (1986)
  • Cited by (236)

    • Adeno-associated viral vector-mediated preprosomatostatin expression suppresses induced seizures in kindled rats

      2017, Epilepsy Research
      Citation Excerpt :

      For example, they may be neuroprotective and reduce excitability when released during high-frequency neuronal activity (Baraban and Tallent, 2004; Hökfelt, 1991). The endogenous expression and synaptic release of some neuropeptides (Csaba et al., 2004; Schwarzer et al., 1996; Simonato et al., 1998; Sperk et al., 1992) and the expression of their receptor subtypes (Csaba et al., 2005, 2004) is altered by seizure activity, suggesting a role for dysregulated neuropeptide signaling in seizure development and maintenance. Neuropeptides have been shown to suppress seizures in experimental epilepsy (Mazarati and Wasterlain, 2002; Zafar et al., 2012).

    View all citing articles on Scopus
    View full text